Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| REPLIMUNE | 11 | 11 | -3,20 % | ||
| BIONTECH | 7 | 38 | -0,31 % | ||
| NOVAVAX | 7 | 18 | +0,31 % | ||
| SPRINGWORKS THERAPEUTICS | 5 | 11 | -8,65 % | ||
| TRAVERE THERAPEUTICS | 5 | 8 | +20,00 % | ||
| 23ANDME | 4 | 15 | -1,92 % | ||
| VERTEX PHARMACEUTICALS | 4 | 11 | -0,24 % | ||
| CUREVAC | 4 | 10 | -0,20 % | ||
| CRISPR THERAPEUTICS | 4 | 10 | -1,51 % | ||
| BRIDGEBIO PHARMA | 4 | 4 | 0,00 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01:46 | After Data Miss in Lead Cancer Indication, Replimune Maps Path for Oncolytic Virus | 1 | MedCity News | ||
| 00:00 | PTC Therapeutics issues EU, US regulatory updates on Translarna | 1 | Seeking Alpha | ||
| Di | Vertex Pharma (VRTX) Appoints Nancy Thornberry to its Board of Directors | 2 | StreetInsider | ||
| Di | AQEMIA Inks $140M Small Molecule Deal with Sanofi | 2 | Contract Pharma | ||
| Di | Genmab A/S: Capital Increase in Genmab as a Result of Employee Warrant Exercise | 2 | GlobeNewswire (USA) | ||
| Di | Neurocrine Biosciences (NBIX) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Crinecerfont in Congenital Adrenal Hyperplasia | 1 | StreetInsider | ||
| Di | Neurocrine gets FDA breakthrough therapy status for crinecerfont | 1 | Seeking Alpha | ||
| Di | Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split | 1 | GlobeNewswire (USA) | ||
| Di | Canadian regulators authorize updated Novavax COVID-19 vaccine | 5 | Seeking Alpha | ||
| Di | Health Canada authorizes Novavax's updated COVID shot for Omicron | 2 | Reuters | ||
| Di | Novavax's (NVAX) Updated COVID-19 Vaccine Now Authorized in Canada | 3 | StreetInsider | ||
| Di | Seagen gains amid options trades, optimism for FTC approval for Pfizer deal | 5 | Seeking Alpha | ||
| Di | IGM Biosciences to cut 22% of workforce, shut down blood cancer programs | 1 | Seeking Alpha | ||
| Di | IGM Biosciences Inc. (IGMS) Announces Strategic Pipeline Prioritization and Cash Runway Extension | 1 | StreetInsider | ||
| Di | Novavax's Updated COVID-19 Vaccine Now Authorized in Canada | 7 | CNW | ||
| Di | VERTEX PHARMACEUTICALS INC / MA - 8-K, Current Report | 3 | SEC Filings | ||
| Di | Aclaris Therapeutics announces patent license agreement with Sun Pharma for alopecia | 2 | Seeking Alpha | ||
| Di | Vertex Pharmaceuticals Incorporated: Vertex Appoints Nancy Thornberry to its Board of Directors | 287 | Business Wire | Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Nancy Thornberry has been appointed to its Board of Directors as an independent director. Ms. Thornberry has more than 35... ► Artikel lesen | |
| Di | BioCryst Pharmaceuticals, Inc.: BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 2 | GlobeNewswire (USA) | ||
| Di | Aclaris Therapeutics, Inc.: Aclaris Therapeutics Announces Patent License Agreement with Sun Pharma for Alopecia | 4 | GlobeNewswire (USA) |
Seite:
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
